(Reuters) – Medical device maker Baxter International Inc said on Friday it plans to spin off its kidney care units into an independent, publicly traded company in the next 12-18 months.
Baxter is also exploring alternatives for its BioPharma Solutions business, including a potential sale or other separation options, the company said.
(Reporting by Raghav Mahobe in Bengaluru; Editing by Shounak Dasgupta)
